2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z

Machine Perfusion (MP) at 21[deg]C Simulates Hibernation Metabolic Pathways in a Non-Hibernator Mammal.

B. Banan, S. Dobrowolski, G. Michalopoulos, P. Fontes.
Macrophage Specific Deletion of RhoA Impedes Macrophage Functions and Abrogates Chronic Rejection of Cardiac Allograft.

Y. Liu, W. Chen, X. Li, R. Ghobrial, M. Kloc.
Malignancies Contribute to Presensitization with Alloreactive T-Cells in Kidney Transplant Recipients.

T. Schachtner,^1,2 M. Stein,² P. Reinke.^1,2
Management and Outcomes of Upper Extremity Deep Venous Thrombosis in Heart Transplant Patients.

A. Panakos,¹ D. Kramer,¹ M. McCarey,¹ P. Mather.²
Management of Recurrent aHUS After Adult Kidney transplantation Despite Eculizumab Prophylaxis.

M. Morton,¹ R. Chinnadurai,¹ S. Ahmed,² A. Sharma,² T. Dutt,² S. Bhutani,¹ H. Denley,¹ T. Augustine,¹ T. Goodship,³ N. Sheerin,³ M. Picton.¹
Managing the Kidney Waiting List: Pride and Prejudice.

F. Smith,¹ C. Sheehan,¹ A. Farney,¹ J. Rogers,¹ G. Orlando,¹ A. Reeves-Daniel,² A. Palanisamy,² R. Stratta.¹
Many Discarded Kidneys Are Similar to Kidneys Accepted for Transplantation as Judged by Their Histologic Lesions and Molecular AKI Scores.

K. Famulski,¹ J. Reeve,¹ O. Aubert,² A. Loupy,² S. Niderhaus,³ J. Bromberg,³ P. Halloran.¹
Mapping Heterogeneity in Antibody-Mediated Rejection Using Molecular Phenotypes and Archetype Analysis.

J. Reeve,¹ P. Halloran.^1,2
Marked Alterations in Gene Expression in Peripheral Blood Leukocytes of Kidney Transplant (tx) Recipients Following Mycophenolic Acid (MPA) Treatment.

K. Sanghavi,¹ B. Wu,¹ C. Dorr,² A. Muthuswamy,² W. Guan,¹ D. Schladt,² R. Remmel,¹ D. Ilke,³ A. Matas,¹ A. Israni,² W. Oetting,¹ P. Jacobson.¹
Markers of Activation of Microvascular Endothelial Cells Predict a Poor Long-Term Graft Outcome in Early Renal Graft Biopsies Displaying Acute Tubular Necrosis.

Y.-C. Dubois-Xu,¹ P. Ahmadpoor,¹ A. Corchia,¹ D. Buob,² P. Galichon,¹ I. Brochériou,¹ C. Suberbielle,³ A. Hertig,¹ E. Rondeau.¹
Mass Cytometry Reveals NK Cell and T Cell Subsets in Pediatric Liver Transplant Patients with Acute Rejection.

A. Lau,^1,2 K. Haas,¹ T. Shawler,² C. Esquivel,² O. Martinez,² R. Castillo,¹ S. Krams.²
Matrix Metalloproteinase-2 (MMP-2) Activity Protects Against Hepatic Ischemia Reperfusion Injury Through MMP-9-Dependent and MMP-9-Independent Mechanisms.

S. Duarte, P. Matian, H. Kato, R. Busuttil, A. Coito.
Matrix Metalloproteinase-9 in Human Orthotopic Liver Transplant Biopsies.

S. Duarte, N. Datta, J. Baber, R. Busuttil, A. Zarrinpar, A. Coito.
Measured Glomerular Filtration Rate of the Remaining Kidney Divided by Its Volume Prior to Donation Is a Predictor of the Long-Term Gain of Function in Living Kidney Donors.

M. Courbebaisse,¹ F. Gaillard,² A. Le Nestour,⁴ J.-M. Correas,³ H. Slimani-Thevenet,⁵ C. Leon,² D. Eladari,¹ M.-O. Timsit,⁶ P. Otal,⁷ G. Friedlander,¹ P. Houillier,¹ N. Kamar,⁸ C. Legendre.²
Measuring Efficacy of Antibody Removal Therapies: Back to Titers.

A. Tambur,¹ D. Glotz,² N. Herrera,¹ E. Chatroop,¹ T. Roitberg,¹ J. Friedewald,¹ D. Gjertson.³
Mechanical Thrombectomy for the Treatment of Pancreas Transplant Venous Thrombosis: A Single Center Experience.

S. Shin,¹ H. Ko,² K. Ko,² Y. Kim,¹ J. Choi,¹ J. Jung,¹ D. Han.¹
Mechanism of FK506 Induced TNF Related Apoptosis in Jurkat T Cells.

S. Chung, S. Choi.
Mechanisms of Alloantigen-Specific Regulation After Donor Specific Transfusion and Costimulatory Blockade in YFP-Foxp3/TdTomRed-Ebi3 Marker Mice.

Y. Tomita,¹ W. Bracamonte-Baran,¹ D. Vignali,² W. Burlingham.¹
Mechanisms of Cellular Repopulation within Healthy or Intrinsically Scarred Kidney Extracellular Matrix Scaffolds.

J. Uzarski,¹ C. Deaton,⁵ H. Ward,² A. Wandinger-Ness,³ W. Miller,⁴ J. Wertheim.¹
Mechanistic Insights into How Targeting of HDAC10 Promotes Foxp3+ Treg Cell Suppressive Activity, Gene Expression and Metabolism, and Enhances Allograft Survival.

S. Dahiya,¹ L. Wang,¹ U. Beier,^1,2 A. Angelin,¹ R. Han,¹ D. Wallace,^1,2 W. Hancock.^1,2
Medicaid Insurance Is Associated with Shorter Time to Transplant Listing After LVAD Implantation.

W. Schultz, M. Yin, Y.-A. Ko, J. Vega, A. Morris.
MELD as a Metric for Survival Benefit of Liver Transplantation.

X. Luo, A. Massie, S. Bae, M. Bowring, D. Segev.
Membrane Proteome Profiling Reveals Molecular Changes Associated with Donor-Specific Tolerance to Vascularized Composite Allotransplants.

H.-Y. Cheng,¹ C.-L. Han,² F.-W. Jiang,² L.-Y. Shih,¹ C.-F. Lin,¹ Y.-J. Chen,³ F.-C. Wei.^1,4
Membranoproliferative Glomerulonephritis Pattern without Immunoglobulin and Complement Deposition in Renal Allograft Was Related to the Injury of Antibody-Mediated Rejection.

J. Wen, F. Xu, J. Chen, X. Li, M. Zhang, Z. Zhang, Z. Liu.
Memory Regulatory T Cell: A Potential Actor in Immunological Operational Tolerance in Kidney-Transplant Patients via the ATP Degradation into Adenosine.

M. Durand,^1,2 F. Braza,¹ N. Degauque,¹ F. Dubois,² M. Chesneau,¹ P. Guérif,^1,3 M. Giral,^1,3 S. Brouard.¹
Mesenchymal Stem Cells Reprogram Macrophage Polarization and Attenuate Liver Ischemia and Reperfusion Injury by Regulating Notch/Cox2/PGE2 Signaling Pathway.

C. Li,¹ S. Yue,¹ R. Busuttil,¹ J. Kupiec-Weglinski,¹ B. Ke.¹
Metabolic Dysregulation and Mitochondrial Dysfunction Are Key Features of Injury Profiles of Donor Kidneys After Brain Death.

M. Lo Faro,¹ M. Akhtar,¹ H. Huang,¹ M. Kaisar,¹ R. Robolledo,² K. Morten,¹ L. Heather,¹ A. Dona,³ H. Leuvenink,² S. Fuggle,¹ B. Kessler,¹ C. Pugh,¹ R. Ploeg.¹
Metabolic Recovery and Ex Vivo Simulation of Early Liver Reperfusion.

B. Bruinsma,¹ J. Avruch,² G. Sridharan,¹ P. Weeder,¹ N. Karimian,¹ J. Markmann,² K. Uygun,¹ H. Yeh.²
Metabolomic Profiles of Hepatocellular Carcinoma and Cirrhotic Patients Before and After Transplantation.

C. Desai,¹ R. Varghese,² S. Robertazzi,¹ C. Di Poto,² A. Ferrarini,² C. Tu,² R. Girlanda,¹ K. Khan,¹ T. Fishbein,¹ H. Ressom.²
Metabolomic Profiling of Individuals with Failing Kidney Allograft.

R. Bassi,^1,2 M. Niewczas,³ L. Biancone,⁵ S. Bussolino,⁵ A. Lin,⁴ A. Chandraker,⁶ P. Fiorina.^1,2
Metallothionein Accelerates Anti-MHC Induced Small Airway Obliteration and Fibrosis by Negatively Regulating IL-10 and Regulatory Cells.

D. Nayak,^1,2 F. Zhou,¹ N. Benshoff,¹ T. Mohanakumar.^1,2
MHC/HLA-Specific IgE in Allotransplantation.

A. Farkas,¹ U. Baranyi,¹ L. Unger,¹ B. Mahr,¹ K. Hock,¹ N. Pilat,¹ H. Regele,² M. Wahrmann,³ G. Böhmig,³ R. Valenta,⁴ T. Wekerle.¹
Microarray Analysis of Transbronchial and Mucosal Biopsies in Lung Transplant Recipients Detects Molecular Changes of T-Cell Mediated Inflammation.

K. Halloran,¹ J. Chang,² V. Ramassar,² J. Weinkauf,¹ A. Kapasi,¹ D. Lien,¹ J. Reeve,² P. Halloran.^1,2
Microfluidics to Characterize Leukocyte Trafficking into Allografts and the Resolution of Inflammation.

L. Boneschansker,^1,2 D. Irimia,² D. Briscoe.¹
MicroRNA let-7i Regulates Dendritic Cells Maturation Targeting Interleukin-10 via JAK1-STAT3 Signal Pathway Subsequently Induces Prolonged Cardiac Allograft Survival in Rats.

X. Jin,¹ Y. Sun,² X. Liu,² J. Wang,¹ S. Xu,¹ L. Yao,¹ Z. Zhao,³ L. Jiang,⁴ Q. Wu,⁵ J. Wu.²
MicroRNA-375 and -200c Are a Set of Novel Biomarkers That Can Predict Islet Autotransplantation Outcome.

G. Yoshimatsu,¹ M. Kanak,² M. Takita,¹ S. Prathab Balaji,¹ C. Chang,¹ M. Lawrence,¹ M. Levy,² N. Onaca,³ P. Kim,³ B. Naziruddin.³
MicroRNAs in Urinary Sediments as Non-Invasive Tool to Detect Acute Rejection After Kidney Transplantation.

E. Gielis,^1,2 J. Anholts,² H. de Fijter,³ I. Bajema,⁴ F. Claas,² M. Eikmans.²
Minimum Graft Size Avoiding Small-for-Size Associated Early Graft Failure in Living Donor Liver Transplantation.

S. Marubashi,¹ H. Nagano,³ H. Eguchi,² H. Wada,² K. Umeshita,² Y. Doki,² M. Mori,² N. Sato,¹ T. Kimura,¹ A. Kenjyo,¹ M. Gotoh.¹
Mining the Human Proteome for Monitoring Renal Transplant Injury.

T. Sigdel,¹ Y. Gao,² J. He,² A. Wang,¹ C. Nicora,² D. Smith,² W. Qian,² D. Camp,² M. Sarwal.¹
miR-21 in Chronic Allograft Vasculopathy.

V. Usuelli,¹ M. Ben Nasr,^1,2 F. D'Addio,^1,2 L. Kaifeng,² L. Borgese,³ L. Potena,³ A. Solini,⁴ C. Rossi,⁴ A. Secchi,¹ D. Corradi,⁵ N. Chau,⁶ P. Fiorina.^1,2
MiRNA-200b Inhibits Epithelial-Mesenchymal Transition in TGF-β1 Induced Human Bronchial Epithelial Cells.

S. Ladak, C. Ward, S. Ali.
Missed Opportunities After Cardiac Death: Should Every Donation After Cardiac Death (DCD) Referral Be Pursued? A Large Single US Organ Procurement Organization (OPO) Experience.

S. Rudich, R. Messer, R. Pietroski, P. Lange.
Mitochondrial Membrane Potential Correlates with Ischemic Injury and Kidney Graft Function in Rats.

M. Chen, J. Huang, L. Qi, S. Kwon, R. Montgomery, Z. Sun.
Modification of DC Phenotype and Function via Targeted Porous Silicon Nanoparticles.

S. Stead,¹ S. McInnes,² S. Kireta,³ P. Rose,¹ D. Rojas-Canales,³ S. Jesudason,³ S. Grey,⁴ R. Carroll,³ N. Voelcker,² P. Coates.^1,3
Modified Normothermic Extracorporeal Liver Perfusion for Discarded Human Livers.

B. Banan,¹ R. Watson,² M. Xu,¹ Y. Lin,¹ W. Chapman.¹
Molecular Assessment of Kidney Transplant Biopsies Performs Similarly in Medulla and Cortex.

K. Madill-Thomsen,¹ J. Reeve,¹ G. Bohmig,² F. Eskandary,² P. Halloran.^1,3
Molecular Diagnosis of Antibody-Mediated Rejection in Routine Formalin-Fixed Paraffin-Embedded Nonhuman Primate Renal Allograft Biopsies.

B. Adam,¹ I. Rosales,² T. Oura,² R. Smith,² A. Cosimi,² T. Kawai,² R. Colvin,² M. Mengel.¹
Molecular Profiles of Renal Allograft Rejection.

Z. Hajjiri, P. Finn, D. Perkins.
Molecular Significance of Microvascular Inflammation and C4d Negative Transplant Glomerulopathy.

M. Lubetzky,¹ P. O Broin,² Y. Bao,¹ E. Akalin.¹
Monitoring of De Novo DSA Post Alemtuzumab Induction in Renal Transplant Recipients: One Year Follow Up.

Y. Nigatu, C. Estrada, F. Darras, H. Suh, M. Abate, E. Nord.
Monocyte Recruitment to HLA Class I Antibody-Activated Endothelial Cells Is Dependent Upon mTOR.

S. Salehi, E. Reed.
Monocytic TNF-α Response to EBV Peptides as a Mean to Identify Over-Immunosuppressed Kidney Transplant Recipients.

P. Vallin,¹ O. Désy,¹ S. Béland,¹ E. Wagner,² S. De Serres.¹
Morbid Obesity and Functional Status as Predictors of Surgical Complication After Renal Transplantation.

T. Veasey, J. Fleming, S. Strout, R. Miller, N. Pilch, H. Meadows, C. Mardis, B. Mardis, P. Baliga, J. McGillicuddy, D. Taber.
Morbidity and Mortality of Early Post-Operative Acute Kidney Injury in Cardiothoracic Transplant Recipients.

J. Casale, A. Logan, C. Doligalski.
Mortality and Graft Loss Attributable to Readmission Following Kidney Transplantation.

E. King, M. Bowring, L. Kucirka, M. McAdams-DeMarco, A. Massie, D. Segev.
Mothers Are Often Sensitized and Sensitive: Antibody Mediated Rejection in Child to Mother Living Donor Liver Transplantation.

B. Movahedi,¹ N. Yu,² P. Martins,¹ A. Ahearn,¹ J. Stoff,¹ A. Bozorgzadeh.¹
Motivation and Stress Associated with Non-Directed Kidney Donation.

J. Wiseman,¹ D. Berglund,¹ C. Jacobs,¹ D. Larson,¹ C. Garvey,¹ M. Vogues, S. Rein,¹ O. Sanchez,¹ C. Radecki Breitkopf,² H. Ibrahim,¹ A. Matas.¹
mRNA Expression of BAFF and APRIL Receptors Increases in Acute Rejection in Kidney Transplant Recipients.

M. Minz,¹ R. Dhital,¹ R. Minz,² A. Sharma,¹ R. Nada,³ S. Singh,¹ D. Kenwar.¹
mTORC2 Negatively Regulates Dendritic Cell (DC) Metabolism and the Allostimulatory Function of Donor DCs in Organ Transplantation.

A. Watson,^1,2 D. Raïche-Regué,¹ H. Dai,¹ K. Fabian,^3,4 G. Delgoffe,^4,5 W. Storkus,^3,4 A. Thomson.^1,2
Multifactorial Prediction of Biliary Stricture After Liver Transplantation: The Impact of Platelet Counts.

K. Takahashi, K. Putchakayala, M. Rizzari, K. Collins, S. Nagai, A. Yoshida, M. Abouljoud, G. Schnickel.
Multiorgan Procurement a Learning Tool in General Surgical Resident Education.

J. Bayer, R. Goldstein, G. McKenna, G. Testa, R. Ruiz, T. Anthony, N. Onaca, G. Klintmalm, P. Kim.
Multiplex Profiling of Plasma Proteins After Xenogenic Lung Exposure.

A. Azimzadeh,¹ N. Cheng,¹ X. Cheng,¹ E. Schwartz,¹ L. Burdorf,¹ S. Dahi,¹ N. Kubicki,¹ D. Parsell,¹ T. Zhang,¹ D. Cooper,² C. Phelps,³ D. Ayares,³ R. Pierson III.¹
Muscle Density Is Associated with Mortality Among Kidney Waitlist Candidates.

R. Reed,¹ S. Nair,² G. Smith,¹ C. Lewis,¹ J. Terry,² J. Carr,² J. Locke.¹
Muscle Function, Mass, and Quality in Obese Liver Transplant Candidates: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study.

C. Wang, I. Lobach, J. Lai.
Mycophenolate Mofetil Dose Reduction Are Associated with the Risk of Acute Rejection and Graft Failure After Renal Transplantation.

A. El-Agroudy,¹ A. Taher,² A. Alaradi,² B. Alhayki,² S. Gareeb,² E. Farid.²
Mycophenolate Mofetil Single Dose Pharmacokinetics Following Laparoscopic Sleeve Gastrectomy.

A. Leino,¹ A. Lichvar,¹ T. Kaiser,¹ U. Christians,³ T. Mizuno,² T. Fukuda,² R. Alloway,¹ A. Vinks,² E. Woodle,¹ T. Diwan.¹
Mycophenolic Acid Product Discontinuation Prior to Conception: Analysis of Pregnancies in Kidney Transplant Recipients.

S. Constantinescu,^1,2 L. Coscia,² D. Armenti,² M. Moritz.^2,3
Myeloid-Derived Suppressor Cells (MDSC) Accumulate in Intestinal Transplant (IT) Patients.

S. Okano,¹ K. Hashimoto,¹ K. Abu-Elmagd,¹ J. Fung,¹ D. Kish,² K. Keslar,² B. Min,² R. Fairchild,² C. Miller.¹

Jump to: View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z